196 related articles for article (PubMed ID: 24601691)
1. Masked and overt autoantibodies specific to the DPD epitope of 65-kDa glutamate decarboxylase (GAD65-DPD) are associated with preserved β-cell functional reserve in ketosis-prone diabetes.
Oak S; Gaur LK; Radtke J; Patel R; Iyer D; Ram N; Gaba R; Balasubramanyam A; Hampe CS
J Clin Endocrinol Metab; 2014 Jun; 99(6):E1040-4. PubMed ID: 24601691
[TBL] [Abstract][Full Text] [Related]
2. Association of amino-terminal-specific antiglutamate decarboxylase (GAD65) autoantibodies with beta-cell functional reserve and a milder clinical phenotype in patients with GAD65 antibodies and ketosis-prone diabetes mellitus.
Hampe CS; Nalini R; Maldonado MR; Hall TR; Garza G; Iyer D; Balasubramanyam A
J Clin Endocrinol Metab; 2007 Feb; 92(2):462-7. PubMed ID: 17090641
[TBL] [Abstract][Full Text] [Related]
3. Presence or absence of a known diabetic ketoacidosis precipitant defines distinct syndromes of "A-β+" ketosis-prone diabetes based on long-term β-cell function, human leukocyte antigen class II alleles, and sex predilection.
Nalini R; Ozer K; Maldonado M; Patel SG; Hampe CS; Guthikonda A; Villanueva J; O'Brian Smith E; Gaur LK; Balasubramanyam A
Metabolism; 2010 Oct; 59(10):1448-55. PubMed ID: 20170930
[TBL] [Abstract][Full Text] [Related]
4. Islet-specific T-cell responses and proinflammatory monocytes define subtypes of autoantibody-negative ketosis-prone diabetes.
Brooks-Worrell BM; Iyer D; Coraza I; Hampe CS; Nalini R; Ozer K; Narla R; Palmer JP; Balasubramanyam A
Diabetes Care; 2013 Dec; 36(12):4098-103. PubMed ID: 24130366
[TBL] [Abstract][Full Text] [Related]
5. HLA class II alleles specify phenotypes of ketosis-prone diabetes.
Nalini R; Gaur LK; Maldonado M; Hampe CS; Rodriguez L; Garza G; Lernmark A; Balasubramanyam A
Diabetes Care; 2008 Jun; 31(6):1195-200. PubMed ID: 18316396
[TBL] [Abstract][Full Text] [Related]
6. Autoantibody epitopes to the smaller isoform of glutamate decarboxylase do not differ in Swedish and Japanese type 1 diabetes patients and may be associated with high-risk human leucocyte antigen class II alleles.
Maruyama T; Oak S; Hall TR; Banga JP; Ortqvist E; Ettinger RA; Endl J; Hampe CS
Clin Exp Immunol; 2007 Dec; 150(3):416-21. PubMed ID: 17956579
[TBL] [Abstract][Full Text] [Related]
7. Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies.
Gambelunghe G; Forini F; Laureti S; Murdolo G; Toraldo G; Santeusanio F; Brunetti P; Sanjeevi CB; Falorni A
Clin Endocrinol (Oxf); 2000 May; 52(5):565-73. PubMed ID: 10792335
[TBL] [Abstract][Full Text] [Related]
8. GAD65-specific autoantibodies enhance the presentation of an immunodominant T-cell epitope from GAD65.
Reijonen H; Daniels TL; Lernmark A; Nepom GT
Diabetes; 2000 Oct; 49(10):1621-6. PubMed ID: 11016444
[TBL] [Abstract][Full Text] [Related]
9. DPD epitope-specific glutamic acid decarboxylase (GAD)65 autoantibodies in children with Type 1 diabetes.
Bansal N; Hampe CS; Rodriguez L; O'Brian Smith E; Kushner J; Balasubramanyam A; Redondo MJ
Diabet Med; 2017 May; 34(5):641-646. PubMed ID: 26802570
[TBL] [Abstract][Full Text] [Related]
10. Unique epitopes of glutamic acid decarboxylase autoantibodies in slowly progressive type 1 diabetes.
Kobayashi T; Tanaka S; Okubo M; Nakanishi K; Murase T; Lernmark A
J Clin Endocrinol Metab; 2003 Oct; 88(10):4768-75. PubMed ID: 14557453
[TBL] [Abstract][Full Text] [Related]
11. Epitope-restricted 65-kilodalton glutamic acid decarboxylase autoantibodies among new-onset Sardinian type 2 diabetes patients define phenotypes of autoimmune diabetes.
Maioli M; Alejandro E; Tonolo G; Gilliam LK; Bekris L; Hampe CS; Obinu DA; Manconi A; Puddu L; Lynch K; Lernmark A;
J Clin Endocrinol Metab; 2004 Nov; 89(11):5675-82. PubMed ID: 15531528
[TBL] [Abstract][Full Text] [Related]
12. Autoantibody recognition of COOH-terminal epitopes of GAD65 marks the risk for insulin requirement in adult-onset diabetes mellitus.
Falorni A; Gambelunghe G; Forini F; Kassi G; Cosentino A; Candeloro P; Bolli GB; Brunetti P; Calcinaro F
J Clin Endocrinol Metab; 2000 Jan; 85(1):309-16. PubMed ID: 10634404
[TBL] [Abstract][Full Text] [Related]
13. HLA class II alleles susceptibility markers of type 1 diabetes fail to specify phenotypes of ketosis-prone diabetes in adult Tunisian patients.
Laadhar L; Harzallah F; Zitouni M; Kallel-Sellami M; Fekih M; Kaabachi N; Slimane H; Makni S
Exp Diabetes Res; 2011; 2011():964160. PubMed ID: 21461382
[TBL] [Abstract][Full Text] [Related]
14. GAD65 autoantibody responses in Japanese latent autoimmune diabetes in adult patients.
Maruyama T; Oak S; Shimada A; Hampe CS
Diabetes Care; 2008 Aug; 31(8):1602-7. PubMed ID: 18487477
[TBL] [Abstract][Full Text] [Related]
15. Autoantibody profile and epitope mapping in latent autoimmune diabetes in adults.
Falorni A; Calcinaro F
Ann N Y Acad Sci; 2002 Apr; 958():99-106. PubMed ID: 12021088
[TBL] [Abstract][Full Text] [Related]
16. The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes.
Oak S; Gilliam LK; Landin-Olsson M; Törn C; Kockum I; Pennington CR; Rowley MJ; Christie MR; Banga JP; Hampe CS
Proc Natl Acad Sci U S A; 2008 Apr; 105(14):5471-6. PubMed ID: 18367670
[TBL] [Abstract][Full Text] [Related]
17. Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus.
Kim J; Namchuk M; Bugawan T; Fu Q; Jaffe M; Shi Y; Aanstoot HJ; Turck CW; Erlich H; Lennon V; Baekkeskov S
J Exp Med; 1994 Aug; 180(2):595-606. PubMed ID: 7519242
[TBL] [Abstract][Full Text] [Related]
18. High GAD65 autoantibody levels in nondiabetic adults are associated with HLA but not with CTLA-4 or INS VNTR.
Rolandsson O; Hägg E; Janer M; Rutledge E; Gaur LK; Nilsson M; Hallmans G; Lernmark A
J Intern Med; 2003 Apr; 253(4):447-53. PubMed ID: 12653874
[TBL] [Abstract][Full Text] [Related]
19. HLA class II is associated with the frequency of glutamic acid decarboxylase M(r) 65,000 autoantibodies in Japanese patients with insulin-dependent diabetes mellitus.
Kasuga A; Falorni A; Maruyama T; Ozawa Y; Grubin CE; Matsubara K; Takei I; Saruta T; Scheynius A; Lernmark A
Acta Diabetol; 1996 Jul; 33(2):108-13. PubMed ID: 8870811
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal changes in epitope recognition of autoantibodies against glutamate decarboxylase 65 (GAD65Ab) in prediabetic adults developing diabetes.
Hampe CS; Hall TR; Agren A; Rolandsson O
Clin Exp Immunol; 2007 Apr; 148(1):72-8. PubMed ID: 17286757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
